Primary outcome
REMISSION
During the follow-up period, the difference in the binary clinical composite outcome was measured to compare the remission rate. Results showed that 50% of patients in the AZA groups achieved remission within the first year of treatment, while only 5% of the control group showed remission. By the end of the follow-up period, a higher remission rate was observed in the AZA1 and AZA2 groups compared with the control group (87.5%, 87.5% Comparison between the three studied groups for 2 years after remission.IQR, Interquartile range.Kaplan-Meier survival curve for three years; showed patients receiving Azhatioprine add on had a significant higher remission rate.